PLA2G4A, phospholipase A2 group IVA, 5321

N. diseases: 202; N. variants: 15
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0585442
Disease: Osteosarcoma of bone
Osteosarcoma of bone
0.020 AlteredExpression disease BEFREE Overexpression of cytosolic phospholipase A2 (cPLA<sub>2</sub>) has been shown to promote progression in several types of cancers, but its functions in OS have not been investigated. 31003849 2019
CUI: C0585442
Disease: Osteosarcoma of bone
Osteosarcoma of bone
0.020 Biomarker disease BEFREE Moreover, with the protection of acetone against tissue antigenicity, we successfully characterized the expression of three metabolites-related enzymes, fatty acid synthase (FASN), glutaminase (GLS), and cytosolic phospholipase A2 (cPLA2) in osteosarcoma. 31404800 2019